Sign In
18 Nov 2015 15:02
ο»Ώ
AMENDMENT(Section 2a) Β
Β FORM 38.5(a)
Β
IRISHΒ TAKEOVERΒ PANEL
Β
DISCLOSUREΒ UNDERΒ RULEΒ 38.5(a)Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997, TAKEOVER Β RULES,Β 2013
Β
DEALINGS BY CONNECTEDΒ EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARYΒ STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
Β
Β
1. KEYΒ INFORMATION
Β Name of exempt market-maker | Morgan Stanley & Co. International plc |
Β Company dealt in | PFIZER INC |
Β Class of relevant security to which the dealings being disclosed relate (Note 1) | US$0.05 COMMON STOCK |
Β Date of dealing | 16 NOVEMBER 2015 |
Β
Β
2. DEALINGSΒ (NoteΒ 2)
Β
(a) PurchasesΒ andΒ sales
Β Total number of relevant secuities accquired | Β Highest price paid (Note 3) | Β Lowest price paid (Note 3) |
Β Β 179 | Β 31.0200 EUR | Β 30.7500 EUR |
Β Β 276,546 | Β 33.3854 USD | Β 33.0350 USD |
Β
Β Total number of relevant secuities disposed | Β Highest price paid (Note 3) | Β Lowest price paid (Note 3) |
Β Β 105 | Β 31.1700 EUR | Β 30.9000 EUR |
Β Β 273,498 | Β 33.3854 USD | Β 33.0365 USD |
Β
Β
(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)
Β
Β Product name, e.g. CFD | Β Nature of transaction (Note 4) | Β Number of relevant securities (Note 5) | Β Price per unit |
Β CFD | Β LONG | Β 105 | Β 30.9903 EUR |
Β CFD | Β SHORT | Β 179 | Β 30.8764 EUR |
Β CFD | Β LONG | Β 1,125 | Β 33.0010 USD |
Β CFD | Β SHORT | Β 200 | Β 32.9400 USD |
Β CFD | Β SHORT | Β 3,357 | Β 32.9549 USD |
Β CFD | Β SHORT | Β 20,371 | Β 33.0508 USD |
Β CFD | Β SHORT | Β 400 | Β 33.0825 USD |
Β CFD | Β SHORT | Β 8,240 | Β 33.1020 USD |
Β CFD | Β SHORT | Β 350 | Β 33.1600 USD |
Β
Β
(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities
Β
i) Writing,Β selling,Β purchasingΒ orΒ varying
Β
Β Product name, eg call option | Β Writing, selling, purchasing, varying etc | Β Number of securities to which the option relates (Note 5) | Β Exercise Price | Β Type, e.g American, European etc | Β Expiry Date | Β Option money paid/received per unit (Note 3) |
Β N/A | Β N/A | Β N/A | Β N/A | Β N/A | Β N/A | Β N/A |
Β
(ii) Exercising
Β
Β Product name, eg call option | Β Number of securities | Β Exercise price per unit (Note 3) |
Β N/A | Β N/A | Β N/A |
Β
Β
3. OTHER INFORMATION
Β
Agreements, arrangements or understandings relating to options or derivatives
Β
Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Β |
Β Β Β Β Β |
Β
Β
Β Date of disclosure | Β 18 NOVEMBER 2015 |
Β Contact Name | Craig Horsley |
Β Telephone Number | +44(141) 245 7736 |
Β Name of offeree/offeror with which connected | ALLERGAN PLC |
Nature of connection (Note 6) | Advisory |
Β
Follow the stocks
